Abundnz develops and applies bioanalysis methods for use in bio-analytical, pharmacokinetic and toxicokinetic studies of peptides, proteins, oligonucelotides, nanomedicines and small molecule drugs. We also perform biomarker validation studies. Techniques that are available are mass spectrometry (LC-MS), immunoassays (ELISA, SPR imaging) and our novel ultrasensitive assay pAMS.
- Drug clearance profiling of innovative medicines
- Biomarker validation
- LC-MS method development